Approval · Notice of Compliance 23399 · 2020
ADEMPAS: Notice of Compliance 23399
Issued March 31, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23399
- Date
- March 31, 2020
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To revise the product monograph related to concomitant use with CYP or P-gp/BCRP inhibitors, transition from PDE5 inhibitors, and other updates.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADEMPAS | Not yet assigned | — |